We use cookies to improve our services. Read more about how we use cookies and how you can refuse them.
2020
CHRE
Infographics to support smokers quit smoking in the times of COVID-19
Infographics to support smokers quit smoking and prevent the ex-smokers relapse back to smoking: now and in the foreseeable times of high levels of anxiety and stress in the community. Help prevent another significant health calamity after the covid pandemic. You can download and use the infographics: these are free for use for everyone, to help people stay away from cigarettes.
2020
EMCDDA
EMCDDA trendspotter briefing - Impact of COVID-19 on drug services and help-seeking in Europe
Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this outbreak for drug services in Europe, the European Monitoring Centre for Drugs and Drug Addiction instigated a mixed-method trendspotter study to provide a snapshot of the current situation. This exercise provides a rapid assessment of the state of play in respect to the impact of COVID-19 on service provision and help-seeking behaviour among people who use drugs.
2020
National Monitoring Centre for Drugs and Addiction
Drug scene, people who use drugs and addictological services during the COVID-19 emergency in the Czech Republic 1
Rapid assessment of the current situation in the Czech Republic
2020
National Monitoring Centre for Drugs and Addiction
Drug scene, people who use drugs and addictological services during the COVID-19 emergency in the Czech Republic 2
Rapid assessment of the current situation in the Czech Republic
2020
AFEW International
Interruption and Innovation: The impact of policy measures during the COVID-19 pandemic on key and vulnerable populations for HIV, tuberculosis and viral hepatitis in Eastern Europe and Central Asia
2020
NLO
NLO briefing paperCOVID-19 in marginalised groups:challenges, actions and voices
The coronavirus disease (COVID-19) pandemic has created an unprecedented crisis for governments, health systems and societies at large, and has severely impacted the health, lives and livelihood of millions of people worldwide.
Marginalised groups are among people the hardest hit by the COVID-19 pandemic, and yet are among the least protected from it by governmental actions to date. Indeed, the COVID-19 crisis has brought into sharp focus the stark inequities that exist in access to health and social support services for marginalised people who live precariously in Europe, often outside formal healthcare systems and social, labour and legal protection measures.
The Nobody Left Outside coalition has developed this briefing paper for the WHO European Office for Investment for Health
Marginalised groups are among people the hardest hit by the COVID-19 pandemic, and yet are among the least protected from it by governmental actions to date. Indeed, the COVID-19 crisis has brought into sharp focus the stark inequities that exist in access to health and social support services for marginalised people who live precariously in Europe, often outside formal healthcare systems and social, labour and legal protection measures.
The Nobody Left Outside coalition has developed this briefing paper for the WHO European Office for Investment for Health
2020
Correlation European Harm Reduction Network
Voices of Frontline Workers Harm Reduction Responses in the European Region During the COVID-19 Pandemic
This Correlation European Harm Reduction Network
(C-EHRN) report on the impact of COVID-19 on vital
harm reduction services seeks to bring these voices
of front-line workers at drug consumption rooms
(DCR’s), harm reduction outreach teams and
PWUD themselves to highlight their experiences
during the COVID-19 pandemic.
(C-EHRN) report on the impact of COVID-19 on vital
harm reduction services seeks to bring these voices
of front-line workers at drug consumption rooms
(DCR’s), harm reduction outreach teams and
PWUD themselves to highlight their experiences
during the COVID-19 pandemic.
2020
Alliance for Public Health
Lessons from COVID-19to reshape a sustainable response to HIV, TBand HCV among inadequately served populationsin the countries of Eastern Europe and Central Asia
As a result of the COVID-19 pandemic, health systems around the world have to become more robust, flexible, and results-oriented.Changes have been made in the approach that some health systems have taken to the delivery of a range of services, including interventions for the management of HIV and opioid dependence as well as the treatment of tuberculosis (TB) and viral hepatitis C (HCV) among key population groups. Many of these changes have been welcomed by communities, with a window of opportunity to revisit and refresh issues of drug use regulations, policing, amnesty for people in prisons and other closed settings.
2020
AFEW International
“THE IMPACT OF COVID-19 ON CIVIL SOCIETY ORGANISATIONS IN EASTERN EUROPE AND CENTRAL ASIA”
In August 2020 AFEW International conducted a questionnaire among Civil Society Organisations in Eastern Europe and Central Asia to measure the impact of COVID-19 on CSOs in the region. The results of the survey are now published in the report “The impact of COVID-19 on civil society organisations in Eastern Europe and Central Asia”.
2020
WHO
Updates and Guidance on COVID-19 Pandemic
2020
ECDC
Situation Update for the EU/EEA and the UK
2020
European Commission
EU Coronavirus Response Website
2020
Drug Reporter
How Harm Reducers Cope with the COVID-19 Pandemic in Europe?
2020
MAINline
8 Corona-Tips voor Mensen die Drugs Gebruiken
2020
Scottish Drug Forum
Guidance on Contingency Planning for People who Use Drugs and COVID-19 (v1.0)
2020
Echele Cabeza
Consumo de Sustancias Psycoactivas en Cuarentena
2020
Zurich Drug Consumption Rooms
COVID-19 Protocols
2020
Metzineres
Flyer (back)
2020
Energy Control
Party & Drugs in the Time of Coronavirus
2020
Welsh Government
Guidance for Substance Misuse and Homelessness Services (v1.0)
2020
YALE
COVID-19 Guidance: Clinicians & Opioid Treatment Programs
2020
YALE
COVID-19 Guidance: Patients Engaged in Substance Use Treatment
2020
YALE
Guidance for People Who Use Substances on COVID-19
2020
Arild Knutsen
An Open Letter on COVID-19 and PWUD
2020
WHO
Guidance on Preparedness, Prevention & Control of COVID-19 in Prisons & Places of Detention
2020
LANPUD
Drogas y COVID-19
2020
INPUD
Harm Reduction for People Who Use Drugs
2020
Drug Policy Network SEE
Basic Protective Measures Against the New Coronavirus
2020
HRC
COVID-19 – Guidance for People Who Use Drugs & Harm Reduction Programs
2020
CREW
Coronavirus – General Hygiene Harm Reduction Tips
2020
UNAIDS
Rights in the time of COVID-19. Lessons from HIV for an effective, community-led response
2020
C-EHRN & EHRA
Harm Reduction Must Go On
2020
Human Rights Watch
Human Rights Dimensions of COVID-19 Response
2020
Global Rights / Susanna Ronconni
Prisoners Rights Matter! Statement
2020
FEANTSA
COVID-19: “Staying Home” Not an Option for People Experiencing Homelessness </span>
2020
ICRSE
COVID-19: Sex Workers Need Immediate Financial Support and Protection
2020
Penal Reform International
Coronavirus: Healthcare and Human Rights of People in Prison
2020
Crack Down
Podcast: Emergency Measures
2020
ISAM
Webinar Series on COVID-19 and Substance Dependence
2020
Foundation for Opioid Response Efforts
Webinar: Medications for Opioid Use Disorder and the COVID-19
2020
HRC
Webinar: Harm Reduction, COVID-19, and People Who Use Drugs
2020
Ten Percent Happier with Dan Harris
Podcast: How to Handle Coronavirus Anxiety | Special Edition</span>
2020
Healing Justice
Coronavirus: Wisdom from a Social Justice Len
2020
WHO
Preventing COVID-19 outbreak in prisons: a challenging but essential task for authorities
2020
COVID-19 and people who use drugs - The Pompidou Group’s Response Platform
2020
WHO Regional Office for Europe
Call to action in response to COVID-19
2020
WHO Regional Office for Europe
Call to action in response to COVID-19 (Russian)
2020
Massimo Caruso
Alfio Distefano
Rosalia Emmal
Michelino Di Rosa
et al
Role of cigarette smoke on ACE-2 protein membrane expression in bronchial epithelial cells using an air-liquid interface model
Prevalence studies of current smoking, among hospitalized COVID-19 patients, demonstrated an unexpectedly low prevalence among patients with COVID-19. The aim of the present study was to evaluate the effect of smoke from cigarettes on ACE-2 in bronchial epithelial cells. Normal bronchial epithelial cells (H292) were exposed to smoke by an air-liquid-interface (ALI) system and ACE-2 membrane protein expression was evaluated after 24 hours from exposure. Our transcriptomics data analysis showed a significant selective reduction of membrane ACE-2 expression (about 25%) following smoking exposure. Interestingly, we observed a positive direct correlation between ACE-2 reduction and nicotine delivery. Furthermore, by stratifying GSE52237 as a function of ACE-2 gene expression levels, we highlighted 1012 genes related to ACE-2 in smokers and 855 in non-smokers. Furthermore, we showed that 161 genes involved in the endocytosis process were highlighted using the online pathway tool KEGG. Finally, 11 genes were in common between the ACE-2 pathway in smokers and the genes regulated during endocytosis, while 12 genes with non-smokers. Interestingly, six in non-smokers and four genes in smokers were closely involved during the viral internalization process. Our data may offer a pharmaceutical role of nicotine as potential treatment option in COVID-19.